- Home
- KRMD vs CRNX Comparison
KRMD vs CRNX Comparison
Compare KRMD & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRMD | CRNX |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.6M | 4.1B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | KRMD | CRNX |
|---|---|---|
| Price | $6.34 | $48.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $5.88 | ★ $71.00 |
| AVG Volume (30 Days) | 194.4K | ★ 992.2K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,070,637.00 | $1,535,000.00 |
| Revenue This Year | $23.36 | $425.41 |
| Revenue Next Year | $18.63 | $943.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 22.12 | ★ 47.74 |
| 52 Week Low | $1.86 | $24.10 |
| 52 Week High | $6.61 | $54.18 |
Technical Indicators
Market Signals| Indicator | KRMD | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 66.31 | 54.60 |
| Support Level | $5.48 | $43.04 |
| Resistance Level | $6.61 | $49.61 |
| Average True Range (ATR) | 0.34 | 2.04 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 70.40 | 62.22 |
Price Performance
Historical ComparisonAbout KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.